Riskpilot← Back to searchSign inGet full accessKemp Medica AB
ABActiveOrg 5590710363Innerspåret 41General medical practice activities · NACE 8621Est. 20160 employees
Revenue 2024
SEK 0
EBITDA margin
—
-697% vs 2023
Equity ratio
21.7%
Financial strength
Net profit 2024
SEK -17K
-697% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -17K | -697% |
| Net profit | SEK -17K | -697% |
| Total assets | SEK 12K | -59% |
| Equity | SEK 3K | -87% |
| Employees | 0 | — |
Legal name
Kemp Medica AB
Org number
5590710363
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
20 juli 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten Firman tecknas ensam av externa firmatecknaren
Company purpose
Bolaget skall bedriva uthyrning av medicinsk personal samt bedriva liknande verksamhet.
Address
Innerspåret 41
Email
katrinrg@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 69 | 121 | 0 | 33 | 0 |
| Staff expenses | — | — | −11 | −0 | −4 |
| EBITDA | 18 | −12 | −65 | −2 | −17 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 18 | −12 | −65 | −2 | −17 |
| Net financials | — | — | — | — | — |
| Profit before tax | 18 | −12 | −65 | −2 | −17 |
| Tax | −4 | −0 | — | — | — |
| Net profit | 14 | −12 | −65 | −2 | −17 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 136 | 97 | 31 | 28 | 12 |
| Equity | 119 | 97 | 21 | 19 | 3 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 18 | 0 | 10 | 9 | 9 |
| Total debt | 18 | — | 10 | 9 | 9 |
EBITDA margin
-1679200.0%
This company
15.8%
Market median
-10627948% vs market
20202024
Equity ratio
21.7%
This company
38.2%
Market median
-43% vs market
20202024
Return on equity
-661.9%
This company
18.4%
Market median
-3697% vs market
20202024
Net profit margin
-1679200.0%
This company
8.1%
Market median
-20730964% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
3.61×
This company
0.62×
Market median
-482% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SE External Signatory | External Signatory | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kemp Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Solveig Edda Cosser | External Signatory | 0 companies |
| Steinunn Thórarinsdóttir | Deputy Board Member | 0 companies |
| Katrin Ragna Kemp Gudmundsdottir | Board of Directors | 0 companies |